Justin Gatwood
University of Tennessee
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Justin Gatwood.
Otolaryngology-Head and Neck Surgery | 2014
Meena Seshamani; Emily Vogtmann; Justin Gatwood; Teresa B. Gibson; Dennis P. Scanlon
Objective To provide information on the prevalence of common complications of adult tonsillectomy and associated health care utilization and expenditures. Study Design Retrospective analysis of a large insurance database. Setting Data from the MarketScan Commercial Claims and Encounters Database. Subjects and Methods Treated prevalence rates for post-tonsillectomy complications were calculated for 36,210 patients with employer-sponsored insurance who had an outpatient tonsillectomy between 2002 and 2007. The relationships with various patient characteristics were examined using multivariate logistic regression. Postoperative emergency department (ED) visits and hospitalizations and total per capita health care expenditures were analyzed. Results This analysis suggests that of adult patients who undergo a tonsillectomy, 20% will have a complication, 10% will visit an ED, and approximately 1.5% will be admitted to a hospital within 14 days of the tonsillectomy. Six percent were treated for postoperative hemorrhage, 2% for dehydration, and 11% for ENT pain within 14 days of surgery. Patients with comorbidities, prior peritonsillar abscess, or an increased number of antibiotic prescriptions in the past year were significantly more likely to develop complications. Three out of 4 patients with postoperative hemorrhage went to the ED (4.63% of all patients), and 50% had a procedural intervention (3.09% overall). The average cost associated with a tonsillectomy was
Drugs | 2012
Justin Gatwood; Martin I. Meltzer; Mark L. Messonnier; Ismael R. Ortega-Sanchez; Rajesh Balkrishnan; Lisa A. Prosser
3832 if no complication. If there was a complication within 14 days, hemorrhage was the most expensive (
Research in Social & Administrative Pharmacy | 2014
Justin Gatwood; Rajesh Balkrishnan; Steven R. Erickson; Lawrence C. An; John D. Piette; Karen B. Farris
6388 vs
Diabetes Technology & Therapeutics | 2016
Alaina Darby; M. Strum; Erin R. Holmes; Justin Gatwood
5753 for dehydration and
Research in Social & Administrative Pharmacy | 2016
Justin Gatwood; Rajesh Balkrishnan; Steven R. Erickson; Lawrence C. An; John D. Piette; Karen B. Farris
4708 for ENT pain). Conclusions Complications of adult outpatient tonsillectomies are common and may be associated with significant morbidity, health care utilization, and expenditures.
International Wound Journal | 2014
Teresa B. Gibson; Vickie R. Driver; James S. Wrobel; James R. Christina; Erin Bagalman; Roy R. DeFrancis; Matthew G. Garoufalis; G. Carls; Justin Gatwood
The recent impact of influenza on the working-age population of the US has led to changes in the recommendations for vaccination against seasonal influenza; however, the implications of vaccinating such a population have been debated. A review of cost-effectiveness analyses of vaccinating the working-age population of the US against seasonal influenza was conducted using articles published between January 1990 and January 2010. Studies considered for inclusion were identified using MEDLINE, EMBASE and Econlit. Reviewers worked in pairs, and each team member independently extracted relevant data using a standard abstraction form. The source and appropriateness of parameters (epidemiological data, probabilities and costs), the designs employed and the sufficiency of sensitivity analysis were considered during review. Key inputs extracted from the selected studies included influenza or influenza-like illness attack rates, outpatient visits averted, total vaccination days and lost workdays.Seven studies were identified as appropriate for this review. All studies were conducted in the US and from the societal perspective; three were randomized controlled trials and the remaining four were economic simulation models comparing vaccination and influenza antiviral drugs or no intervention; analyses focused on healthy working-age adults aged 18–49 years. Results ranged from net savings of
Vascular Health and Risk Management | 2014
Justin Gatwood; James E. Bailey
US68.96 to net costs of
Journal of Medical Economics | 2015
Amy Law; Mark McCoy; Richard Lynen; Suellen M. Curkendall; Justin Gatwood; Paul Juneau; Pamela Landsman-Blumberg
US85.92 per person vaccinated (four studies) and net costs of
Journal of Medical Economics | 2016
Barbara H. Johnson; L.A. Palmer; Justin Gatwood; G.M. Lenhart; Kosuke Kawai; Camilo J. Acosta
US 104-1005 per episode of influenza averted (one study). Only two studies reported cost-effectiveness ratios; these ranged from
The American Journal of Pharmaceutical Education | 2015
Marie A. Chisholm-Burns; Justin Gatwood; Christina A. Spivey
US26 565 to